2013 - ISBTS 2013 Symposium


This page contains exclusive content for the member of the following sections: TTS, IXA, ITA. Log in to view.

Posters and Exhibition

15.90 - Persistent inflammatory enteropathy in infants following surgical resection for necrotising enterocolitis (NEC)with intestinal failure

Presenter: Mandela, Thyoka, , United Kingdom
Authors: Susan Hill1, Mandela Thyoka

Persistent inflammatory enteropathy in infants following surgical resection for necrotising enterocolitis (NEC)with intestinal failure

Susan Hill1, Mandela Thyoka

1Paediatric Gastroenterology, Great Ormond Street Hospital for Children, London, United Kingdom

Purpose: Intestinal failure is a recognised complication following treatment of necrotizing enterocolitis (NEC) in infants. The adaptability of the remaining intestine has an impact on the successful weaning from parenteral nutrition (PN).Our aim was to report 1) immunological profile and  2) macroscopic and microscopic intestinal endoscopic findings among infants who developed IF secondary to NEC.
 
Materials and Methods:We obtained ethical approval to retrospectively review infants with a diagnosis of Bell stage II or III NEC who were consecutively admitted and treated in our unit (2005-2011) and subsequently developed IF. IF was defined according to national guidelines as requirement of parenteral nutrition (PN) >27 days. Infants with IF were managed by a multidisciplinary team led by Paediatric Gastroenterologists who performed the endoscopies based on individualised patient’s clinical needs.
 
Results:During the study period, 33 (23%) out of 148 infants with NEC developed IF. Of 11 (33%) infants [6 (54%) female] with IF who had 15 endoscopy sessions, results were available from 13 sessions.At endoscopy (n=13), macroscopic abnormalities were detected in 5/13 (39%) endoscopies however 9/13 (70%) had microscopic abnormalities on histology. Macroscopic abnormalities were mainly erythema in duodenum (n=2) and colon (n=2); and mucosal contact bleeding (n=1). Microscopic abnormalities were gastro-duodenitis (n=3), duodenitis (n=2), duodenal sub-total villous atrophy (n=1), duodenal intraepithelial lymphocytosis (n=1), increased lamina propria and eosinophil density (n=1) and colitis (n=1). Immunoglobulin profiles (a total of 9 tests from four infants) were: total IgA 0.65 (0.3-0.92), IgM 0.97 (0.59-1.57), IgG 6.72 (3.72-7.45) and IgE 22.4 (3.0-86.7). 8/12 blood IgA levels and 4/9 IgM were borderline low 4/9 blood IgE levels were raised. Overall, 3/33 (9%) infants with IF died, one of these underwent endoscopy.
 
Conclusion:  A third of infants with IF secondary to NEC require endoscopy; a majority of these (70%) have microscopic abnormalities even in the absence of macroscopic abnormalities. Although no patient had a major immunodeficiency low levels of blood IgA and IgM were common. An enteropathy should be considered in infants who are slow to wean from PN treatment and endoscopy with biopsies performed.
Paediatric Surgery, Great Ormond Street Hospital for Children, London WC1N 3JH


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada